Technology News and Research

RSS

Khon Kaen University deploys Aruba's adaptive Wi-Fi networks and AirWave Wireless Management System

Aruba Networks, Inc., a global leader in distributed enterprise network solutions, today announced that Thailand's Khon Kaen University Faculty of Medicine has deployed its adaptive Wi-Fi networks and AirWave Wireless Management System to support X-Ray image archiving, healthcare and drug dosage record access, and Internet access to 2,000 staff members and 1,200 students. The new system replaces legacy Cisco and 3COM autonomous FAT access points, and was deployed by Aruba authorized partner World Information Technology Company.

30 Jun 2010

Mayo Clinic biostatistician become director of CALGB

In a move that will improve efficiency and collaboration in cancer research, Mayo biostatistician Daniel Sargent, Ph.D., will become director of the Statistical Center for the Cancer and Leukemia Group B (CALGB), a national association of cancer researchers funded primarily by the National Cancer Institute (NCI).

30 Jun 2010

SMART-UR launches Client Service Center to assist with medical Utilization Review request process

Gregg Bernhard, COO of SMART-UR, announced the company has launched a Client Services Center to assist its clients with the processing of medical Utilization Review (UR) requests.

30 Jun 2010

Lack of reimbursements limit drug-eluting stent market across Latin America

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, despite the rising popularity of drug-eluting stents (DES) across Latin America, bare-metal stents (BMS) will continue to represent a significant portion of the overall coronary stent market through 2014. This trend is especially evident in Brazil, where the public healthcare system does not provide any reimbursement for DES procedures.

30 Jun 2010

Sirnaomics receives NIH SBIR grants to advance siRNA therapeutics for critical human diseases

Sirnaomics, Inc. announced today that the company has received two SBIR (Small Business Innovation Research) grants from National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases (NIAID), of National Institute of Health (NIH). Sirnaomics, Inc., a biopharmaceutical company founded in early 2007, is dedicated to developing RNA interference (RNAi) therapeutics for treatment of critical human diseases.

30 Jun 2010

Original viral genetic sequences still present months after initial infection, says study

Scientists have been surprised to learn that, despite thousands of changes that viruses like HIV undergo in rapid fashion to evade the body's immune system, the original version that caused the infection is still present in the body months later.

30 Jun 2010

Wishard-Regenstrief partnership earns NAPH President's Award for Health Reform Readiness and Leadership

Wishard Health Services, the nation's third-largest safety net health care system in outpatient visits, and the Regenstrief Institute Inc., an internationally-respected medical and public health informatics innovator, earned the NAPH 2010 President's Award for Health Reform Readiness and Leadership.

30 Jun 2010

AqueSys secures $35 million in Series C financing round

AqueSys, Inc., a medical device company that develops, manufactures and distributes proprietary implants for glaucoma, today announced that it has secured $35 million in Series C financing. The round was led by Longitude Capital and Rho Ventures, with participation from existing investors Accuitive Medical Ventures, The Carlyle Group and SV Life Sciences.

30 Jun 2010

BSP receives European CE conformance mark for HyperQ AD-100 add-on system

BSP, which develops and commercializes advanced products for the non invasive, accurate diagnosis of heart diseases, announced today that its Add-On product, the HyperQ AD-100, intended for improved diagnostic performance of Stress ECG, has been granted the European CE conformance mark.

30 Jun 2010

Novel method of encapsulating gases, liquids and solids using miniature bubbles

Researchers from University College London have won a £25,000 prize for developing technology that could be used to improve medical imaging, the targeted delivery of drugs and much more.

29 Jun 2010

An innovative genetic prediction algorithm

A University of Toledo doctoral candidate in biomedical sciences recently combined the inspiration he received from his grandfather, values learned from his mother, insights gleaned from his mentors and processing power tapped from a supercomputer to unlock a few of the many secrets of the human genome.

29 Jun 2010

Siemens Radiation Reduction Alliance launched

In a continual commitment to patient care and radiation reduction in computed tomography (CT), Siemens Healthcare has launched SIERRA (Siemens Radiation Reduction Alliance) and has established an expert panel to advance the cause of dose reduction in CT. The new Low Dose Expert Panel includes 15 specialists in radiology, cardiology and physics, who are internationally recognized for their publications on the subject of CT dose.

29 Jun 2010

Omnicell's OmniCenter qualifies for VMware Ready logo

Omnicell, Inc., a leading provider of system solutions to acute healthcare facilities, today announced that its OmniCenter® server has achieved VMware Ready™ status. This designation indicates that OmniCenter has passed a detailed evaluation and testing process managed by VMware and is now listed on the VMware Partner Product Catalog.

From Omnicell, Inc. 29 Jun 2010

Claros point-of-care system for PSA receives European CE Mark approval

Claros Diagnostics, a developer of novel point-of-care in vitro diagnostic systems, today announced the CE Mark approval for its rapid quantitative point-of-care diagnostic platform, which can now be used for prostate specific antigen (PSA) testing throughout the European Union. The approved system consists of a small portable analyzer and credit card-sized disposable.

29 Jun 2010

Alnylam receives Portuguese, Swedish, British approvals to initiate ALN-TTR01 Phase I study in ATTR

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that its applications for ALN-TTR01 have been given clearance by Portuguese, Swedish, and British regulatory authorities to begin clinical testing. The trial will begin enrolling patients shortly in a blinded, randomized, placebo-controlled, multicenter Phase I study.

29 Jun 2010

Individual cells react differently to complex signals: Study

Using new technology that allows scientists to monitor how individual cells react in the complex system of cell signaling, Stanford University researchers have uncovered a much larger spectrum of differences between each cell than ever seen before.

29 Jun 2010

Successful growth of mouse embryonic stem cells in rat lungs raises hopes for engineering human transplants

For someone with a severe, incurable lung disorder such as cystic fibrosis or chronic obstructive pulmonary disease, a lung transplant may be the only chance for survival. Unfortunately, it's often not a very good chance. Matching donor lungs are rare, and many would-be recipients die waiting for the transplants that could save their lives.

29 Jun 2010

BIND Biosciences announces $12.4 million Series C-1 financing

BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing best in class therapeutics based on its proprietary targeted nanotechnology platform, announced today that it has secured a $12.4 Million Series C-1 financing. This financing included all of BIND's current investors (including Polaris Venture Partners, Flagship Ventures, ARCH Venture Partners, NanoDimension and DHK Investments) as well as a new venture investor, Endeavour Vision, and private investors.

29 Jun 2010

Study investigates efficacy of SWV measurement in evaluation of NASH pathophysiology using ultrasound

Nonalcoholic steatohepatitis (NASH) is manifestation of metabolic syndrome in the liver and is a pandemic over the globe especially in the developed countries, based on a high calorie diet and sedentary life style. As in the other types of chronic hepatitis, collagen fibers continuously accumulate in the liver through the course of NASH toward cirrhosis and hepatocellular carcinoma development.

29 Jun 2010

New earplug with built-in computer allows speech to pass; shuts out unwanted noise

An earplug with a built-in computer that allows speech to pass but shuts out unwanted and hazardous noise will make life easier in noisy environments.

29 Jun 2010

Technology News and Research

Khon Kaen University deploys Aruba's adaptive Wi-Fi networks and AirWave Wireless Management System

Mayo Clinic biostatistician become director of CALGB

SMART-UR launches Client Service Center to assist with medical Utilization Review request process

Lack of reimbursements limit drug-eluting stent market across Latin America

Sirnaomics receives NIH SBIR grants to advance siRNA therapeutics for critical human diseases

Original viral genetic sequences still present months after initial infection, says study

Wishard-Regenstrief partnership earns NAPH President's Award for Health Reform Readiness and Leadership

AqueSys secures $35 million in Series C financing round

BSP receives European CE conformance mark for HyperQ AD-100 add-on system

Novel method of encapsulating gases, liquids and solids using miniature bubbles

An innovative genetic prediction algorithm

Siemens Radiation Reduction Alliance launched

Omnicell's OmniCenter qualifies for VMware Ready logo

Claros point-of-care system for PSA receives European CE Mark approval

Alnylam receives Portuguese, Swedish, British approvals to initiate ALN-TTR01 Phase I study in ATTR

Individual cells react differently to complex signals: Study

Successful growth of mouse embryonic stem cells in rat lungs raises hopes for engineering human transplants

BIND Biosciences announces $12.4 million Series C-1 financing

Study investigates efficacy of SWV measurement in evaluation of NASH pathophysiology using ultrasound

New earplug with built-in computer allows speech to pass; shuts out unwanted noise

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News